In a remarkable journey that began 15 years ago, Marken has become a driving force in the clinical logistics landscape throughout India. By accelerating the accessibility of new medicines and drugs in development to patients across the country and worldwide, this exciting milestone is a testament to Marken’s passion for improving patients’ lives. From a single office in Mumbai in 2008 to six strategically positioned state-of-the-art logistics, storage and distribution facilities, Marken’s Indian footprint now spans across key cities including Mumbai, Delhi, Bangalore, Hyderabad, Ahmedabad, and Pune, connecting over 280 cities and towns. 

Marken India has been an instrumental leader, pioneering direct-to/from patient services and lifesaving CGT logistics including critical CAR-T therapies. Additional diversification of offerings such as early access programs, shipping qualification and route risk assessments add to Marken’s unique position to support the rising demand within this territory.

Ariette van Strien, Marken’s President, comments, “As we commemorate our remarkable 15-year journey of delivering excellent service in India, I’m proud of all our successes and continued growth in this emerging region — In 2008, we started with one site and, today, are operating in six cities with a robust network and an exceptional team. I had the privilege of meeting with the Marken India team earlier this year and was impressed by their passion for our Indian clients and their patients.

India remains a focus for us, holding incredible potential in drug development, vaccines, biosimilars, and CGT. Among the top 3 countries in the pharma industry for producing new medicines, we will continue to invest in India, expanding in this significant market. Thank you to our teams in India for continuing to go beyond to deliver what matters.”

Marken’s Vice President, Asia Pacific, Poh-Meng Cheah adds, “Over the past few years, Team India has come out stronger, and I am pleased that we have moved to larger and better facilities in almost all branches. With this, everyone looks forward to the next 5 years in anticipation of moving the company to an even higher echelon of achievement. Here we go again, one team one fight!”

As India emerges as a preferred country for pharmaceutical production, Marken remains at the forefront by expanding our presence and drug storage and distribution capabilities to areas where our clients’ clinical trials and patient populations are increasing.